Hospital Based Cause Of Death Statistics

إحصاءات نظام إبلاغ أسباب الوفيات من المستشفيات

A National Hospital Based Mortality Notification system (HMS) was established at the beginning of 2017 in collaboration with the World Health Organization and in cooperation with the Syndicate of hospitals as an expansion of the maternal and neonatal death reporting system established in 2011. The system consists of anonymous online reporting of deaths based on an excerpt of the official death certificate form. Focal points were assigned and trained in more than 150 public and private hospitals operating in Lebanon. After reporting the information, quality checks are initiated through constant communication between the statistics department and the hospitals’ focal points. After that, the underlying cause of death is selected from the reported causes of the death.

Hospital Mortality Statistics 2025

Hospital Deaths due to COVID-19 by Week, 2020-2025 (till August 2025)

Hospital Deaths due to COVID-19 by Month, 2020-2025 (till August 2025)

Hospital Mortality Statistics 2024

Number of reported hospital deaths and proportional mortality due to malignant neoplasms, 2017-2024

Top Cancer Killers In Men and Women,2024

Hospital Mortality Statistics 2022

Top Cancer Killers in Men and Women, 2022

Hospital Mortality Statistics 2021

Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group

Weekly Total Hospital Deaths and COVID19 Related Deaths

Hospital Mortality Statistics 2020 and 2021

Weekly Total Hospital Deaths and COVID19 Related Deaths 2020&2021

Hospital Mortality Statistics 2020

Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group in Lebanon

Weekly Total Hospital Deaths and COVID19 Related Deaths

Hospital Mortality Statistics 2019

Number of reported Lebanese hospital deaths by month and age group, 2019

Number of reported hospital deaths by month and age group in Lebanon, 2019 (Updated)

Hospital Mortality Statistics 2018

Number of reported Lebanese hospital deaths by month and age group, 2018

Number of reported hospital deaths by month and age group in Lebanon, 2018 

Hospital Mortality Statistics 2017

Number of reported Lebanese hospital deaths by month and age group, 2017

Number of reported hospital deaths by month and age group in Lebanon, 2017

Reported hospital deaths by top ICD10 chapters, 2017

Top 10 cancers by ICD10 3-character code, 2017

Plot of the number of the reported deaths by size and type of hospital, 2017

Five leading cancer deaths by gender, 2017

Top 10 leading causes of reported hospital deaths by ICD10 4-character code and gender, 2017

Proportion of reported hospital deaths by age group and gender in Lebanon, 2017

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J07CA	LANTIGEN B	B	Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml		Drops suspension	916,501 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 15mg	15mg	Tablet	341,075,567 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg/ml	10mg/ml	Injectable solution	1,584,390 L.L
R01AD09	NASONEX	B	Mometasone furoate (monohydrate) - 50mcg/dose	0.05%	Spray, suspension	529,474 L.L
B03AD04	MALTOFER	B	Iron trivalent (hydroxide polymaltose) - 50mg/ml	50mg/ml	Drops solution	649,076 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	1,032,071 L.L
C10AB04	LOPID	B	Gemfibrozil - 600mg	600mg	Tablet, film coated	498,566 L.L
G04CA04	SILOSIN	B	Silodosine - 4mg	4mg	Capsule	1,251,693 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 125mg/5ml	125mg/5ml	Granules for suspension	487,623 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
L03AX16	MOZOBIL	B	Plerixafor - 20mg/ml	20mg/ml	Injectable solution	413,801,327 L.L
N06AB05	SEROXAT	B	Paroxetine (HCl) - 20mg	20mg	Tablet, film coated	1,586,205 L.L
R01AD09	NASONEX	B	Mometasone furoate (monohydrate) - 50mcg/dose	0.05%	Spray, suspension	529,474 L.L
L01EX05	STIVARGA	B	Regorafenib - 40mg	40mg	Tablet, film coated	L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	1,032,071 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 20mg	20mg	Tablet	341,075,567 L.L
M01AE01	ALGIFAST 400	B	Ibuprofen Lysine - 400mg	400mg	Powder for suspension	473,033 L.L
N02AA59	DOLOSPASMINE COMP	B	Codeine phosphate - 40 mg, Hexahydro-adipenine HCl - 50 mg, Propyphenazone - 500 mg		Suppository	267,489 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
B03AE10	TOT'HEMA	B	Copper (gluconate) - 0.70mg/10ml, Manganese (gluconate) - 1.33mg/10ml, Iron (gluconate) - 50mg/10ml		Solution	604,729 L.L
J07CA06	PENTAXIM	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	2,558,676 L.L
M01AE01	ALGIFAST PEDIATRIC	B	Ibuprofen Lysine - 20mg/ml	20mg/ml	Suspension	393,746 L.L
N03AX14	KEPPRA	B	Levetiracetam - 1000mg	1,000mg	Tablet, film coated	12,202,941 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 40mg	40mg	Tablet	1,846,440 L.L
C10AB05	LIPANTHYL	B	Fenofibrate - 160mg	160mg	Tablet, film coated, modified release	1,154,238 L.L
G04CA04	SILOSIN	B	Silodosine - 8mg	8mg	Capsule	1,927,454 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - ?30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ?40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml		Injectable suspension	4,230,416 L.L
L01EK01	INLYTA	B	Axitinib - 5mg	5mg	Tablet, film coated	184,486,511 L.L

...

189